Physiologic risk factors increase risk of myocardial infarction with transcarotid artery revascularization in

Jane Chung1, Norman H Kumins1, Justin Smith1

  • 1Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Harrington Heart and Vascular Institute, University Hospitals, Case Western Reserve University, Cleveland, OH.

Journal of Vascular Surgery
|December 23, 2022
PubMed

Insights

Transcarotid artery revascularization (TCAR) patients with physiologic risk factors had higher myocardial infarction rates compared to those with anatomic factors. However, combined stroke, death, and MI rates were similar between groups.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Neurosurgery

Background:

  • Patients undergoing carotid endarterectomy (CEA) may be at high risk due to anatomic or physiologic factors, often opting for transcarotid artery revascularization (TCAR).
  • Physiologic risk factors, stemming from significant comorbidities, generally indicate a higher overall surgical risk profile.
  • TCAR is an established procedure for high-risk patients requiring carotid artery revascularization.

Purpose of the Study:

  • To investigate the incidence of stroke, myocardial infarction (MI), and death in patients undergoing TCAR.
  • To stratify outcomes based on whether high-risk criteria were anatomic or physiologic.
  • To compare event rates between TCAR patients with anatomic-only versus at least one physiologic risk factor.

Main Methods:

  • Analysis of prospectively collected data from three TCAR trials (ROADSTER, ROADSTER 2, and extended access).
  • Inclusion of 851 high-risk patients stratified by high-risk anatomic criteria or high-risk physiologic criteria.
  • Primary outcome measures included stroke, death, and MI at 30 days, analyzed using the chi-squared test.

Main Results:

  • Of 851 patients, 372 had anatomic-only risk factors and 479 had at least one physiologic risk factor.
  • Myocardial infarction (MI) occurred in 1.7% of the physiologic group versus 0% in the anatomic group (P = .01).
  • The combined stroke, death, and MI rate was 2.1% in the anatomic cohort and 4.2% in the physiologic cohort (P = .10).

Conclusions:

  • TCAR patients with high-risk physiologic factors exhibited a higher rate of MI compared to those with anatomic criteria.
  • Combined rates of stroke, death, and MI were comparable between the anatomic and physiologic risk groups.
  • The anatomic criteria group represented a healthier, younger patient subset with low overall event rates.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
23